Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
A disaccharide degradation product of chondrotin sulfate proteoglycan-disaccharide (CSPG-DS) has been implicated previously in the inhibition of neurodegeneration by influencing microglia activation. In this study, genome-wide microarray analysis was used to identify specific gene expression profiles of CSPG-DS-stimulated BV-2 microglia-like cells. Gene products involved in phagocytosis, detoxification, migration, immune regulation, and antigen presentation were found to be altered significantly. These findings were replicated and compared with IFN-γ-stimulated primary microglia using real-time quantitative RT-PCR validation. Importantly, a unique transcriptional phenotype with anti-inflammatory and IFN-γ counter-regulatory properties partially related to alternatively activated macrophages was identified. Using functional cell assays, we found that CSPG-DS-stimulated microglia possess increased phagocytic capacity but lack direct cytotoxic effects such as secretion of NO. Furthermore, conditioned media from CSPG-DS-treated microglia did not diminish the viability or cause apoptosis of cultured photoreceptor cells and partially rescued these cells from IFN-γ-induced apoptosis. Taken together, our data provide a unique transcript dataset and important in vitro findings about the functional properties of CSPG-DS-activated microglia. These might be starting points to explore the in vivo role of CSPG-DS as a bioactive microglia regulator and its potential, therapeutic application in immune-related, neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496
Self-citationGrommes, C., Lee, C. Y. D., Wilkinson, B. L., Jiang, Q., Koenigsknecht-Talboo, J. L., Varnum, B., & Landreth, G. E. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9090-2 · Cited by 162 · cited 1×
“Several transcripts in the up-regulated cluster including Gas6, selenoprotein P, Ctype lectin 4n (Clec4n), and Clec7a were previously linked to trophic, anti-inflammatory, and tissue-remodeling functions of embryonic phagocytes [13] and phagocytic microglia [14].”
BackgroundRetina-derived microglial cells induce photoreceptor cell death in vitro
Roque, R. S., Rosales, A. A., Jingjing, L., Agarwal, N., & Al-Ubaidi, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01625-x · Cited by 101 · cited 1×
“2, E–H), which is in agreement with earlier findings [25].”
Result
Cited by
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 877
The bright side of the glial scar in CNS repair
Rolls, A., Shechter, R., & Schwartz, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2591 · Cited by 674
“and products of the enzymatic degradation of CSPG, especially by ChABC, are potent neuroprotective agents and can induce neuronal growt”
BackgroundRetinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
Self-citationMicroglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
“As with macrophages (Benoit et al. 2008; Geissmann et al. 2008; Martinez et al. 2008; Gordon and Taylor 2005), microglia may exhibit an alternatively activated or deactivated M2 phenotype or a classically activated M1 phenotype (Michelucci et al. 2009; Ebert et al. 2008; Komohara et al. 2008; Ponomarev et al. 2007; To…”
BackgroundProtective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
Metadata
- Authors
- Ebert, S., Schoeberl, T., Walczak, Y., Stoecker, K., Stempfl, T., Moehle, C., Weber, B. H. F., & Langmann, T.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-12
- Volume
- 84
- Issue
- 3
- Pages
- 736-740
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2132566567
- Cited by
- 49
- References
- 4
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. https://app.cochat.ai/papers/10.1189/jlb.0208138
- The paper
- Ebert, S., Schoeberl, T., Walczak, Y., Stoecker, K., Stempfl, T., Moehle, C., Weber, B. H. F., & Langmann, T. (2008). Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. Journal of Leukocyte Biology. https://doi.org/10.1189/jlb.0208138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.